Elevated serum IgA following vaccination against SARS-CoV-2 in a cohort of high-risk first respondersArticle Published on 2022-09-022022-11-15 Journal: Scientific Reports [Category] SARS, 진단, [키워드] Administered anti-N IgG anti-S anti-S IgG Anti-spike characterized Cohort elevated elicit evaluated Evidence IgA IgA response IgG IgM/IgG Infection Moderna Neutralizing participant Participants Pfizer positive predominant proportion receiving Responder SARS-CoV-2 SARS-COV-2 infection serum statistically significant difference the vaccine vaccination Vaccine [DOI] 10.1038/s41598-022-19095-7 PMC 바로가기
Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021Article Published on 2022-09-022022-11-16 Journal: BMC Medicine [Category] SARS, 변종, [키워드] adjusted Admissions age AZD1222 BNT162b2 booster Care change changes in Cohort studies cohort study Combination Comorbidities conditions confidence interval country covariate COVID-19 COVID-19 vaccine COVID-19 vaccines death delta variant dominant dose effective Effectiveness facilitated groups hazard heterologous schedules highest hospitalisation hospitalisations Hospitalization Infection intensive care intensive care units knowledge Mortality mRNA mRNA-1273 National Norway pandemic population-based cohort proportional hazards models provided receiving regimen regimens registries remained SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections second dose Sex Support the vaccine vaccination Vaccine vaccine dose vaccine effectiveness waned [DOI] 10.1186/s12916-022-02480-4 PMC 바로가기
Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational studyObservational Study Published on 2022-09-012022-10-04 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 임상, 진단, [키워드] age antibody kinetics approval binding antibody booster CLIA CoronaVac Course COVID-19 COVID-19 vaccines ELISA enzyme-linked immunosorbent evaluate Factors HCW HCWs healthcare worker immunoassay inactivated NAb negative correlation neutralizing antibody optic density Participants Pearson correlation propensity score analysis prospective observational study response SARS-CoV-2 SARS-CoV-2 antibody significant decrease significantly single center the antibody response the vaccine titer Turkey Vaccine Vero Cell was determined was performed were used [DOI] 10.1016/j.ijid.2022.05.007 PMC 바로가기 [Article Type] Observational Study
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adultsResearch article Published on 2022-09-012022-10-05 Journal: Vaccine [Category] 임상, 진단, 치료기술, [키워드] 95 % CI adverse event Adverse events of special interest analyses Analysis baseline Brighton Collaboration Coalition for Epidemic Preparedness Innovations collaboration Combined COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccine trials COVID-19 vaccines datasets evaluate exhibited higher risk Moderna Moderna COVID-19 vaccine mRNA-1273 mRNA mRNA COVID-19 vaccine mRNA vaccine mRNA vaccines NCT04368728 NCT04470427 outcomes Pfizer Pfizer-BioNTech COVID-19 vaccine BNT162b2 Placebo placebo-controlled randomized clinical trial randomized trial reported Result risk Safety Platform for Emergency vACcines SARS-CoV-2 secondary Serious Adverse Event Serious Adverse Events serious COVID-19 stratified the vaccine Trial Vaccines World Health Organization [DOI] 10.1016/j.vaccine.2022.08.036 [Article Type] Research article
Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concernNicotiana benthamiana에서 생산된 SARS-CoV-2 변이체의 수용체 결합 도메인 단백질은 우려되는 변이체에 대한 중화 항체를 유도합니다Article Published on 2022-09-012022-09-11 Journal: Journal of medical virology [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] (alpha Alpha Beta binding domain booster vaccination Booster vaccine cloned COVID-19 cross-reactive Day Delta Delta variants dose Effective vaccines elicit Epsilon evaluated expression vector Fc fragment fragment of Gamma gene encoding health problem human IgG1 immune response immunized immunogenicity induce intramuscularly mutant Mutation Neutralizing antibodies neutralizing antibody Neutralizing antibody response neutralizing antibody responses Nicotiana benthamiana plant-produced recombinant protein produced Protein public health RBD RBD-Fc RBD-Fc fusion protein Receptor-binding domain Recombinant protein required respiratory SARS-CoV-2 SARS-CoV-2 strains SARS-CoV-2 variant SARS-CoV-2 variants Severe acute respiratory syndrome significantly Spread subunit Subunit vaccine tested the receptor-binding domain the vaccine the vaccines transient expression Vaccine variant variant vaccine. variants variants of concern VOCs Wuhan [DOI] 10.1002/jmv.27881 PMC 바로가기 [Article Type] Article
A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adultsArticle Published on 2022-09-012022-11-15 Journal: Clinical and Translational Medicine [Category] SARS, 진단, [키워드] Administered Adults adverse event Adverse reaction China city clinical trial conducted COVID-19 determine District dose doses double-blind Efficacy Efficacy and safety enrolled evaluate group immunization immunogenic incidence intramuscularly Jiangsu live SARS-CoV-2 Local Mild Neutralizing antibody response Older participant Participants Placebo placebo-controlled profile pseudovirus Randomized Randomized controlled trial receive receiving recruited Safety SARS-CoV-2 SARS-CoV-2 vaccine seroconversion rate significantly significantly increased systemic adverse reaction the vaccine Trial trials Vaccine vaccine SCoK. [DOI] 10.1002/ctm2.1016 PMC 바로가기
COVID-19 vaccination, incidence, and mortality rates among indigenous populations compared to the general population in Brazil: Describing trends over timeResearch article Published on 2022-09-012022-10-05 Journal: The Lancet Regional Health - Americas [Category] 진단, [키워드] absence Adults age available data Brazil chronic Coverage COVID-19 COVID-19 incidence COVID-19 pandemic COVID-19 vaccination cumulative cumulative mortality death decrease Describing detrimental Effectiveness extreme finding funding General population health inequities Health inequity heterogeneity implementation incidence incidence rate incidence rates Indigenous populations information Isolation Ministry of Health Mortality mortality rate Older Population populations regions reported resource respond supported the vaccine Trends over time vaccination Vaccination strategy Vaccine [DOI] 10.1016/j.lana.2022.100319 [Article Type] Research article
A systematic review and meta-analysis of immune response against first and second doses of SARS-CoV-2 vaccines in adult patients with hematological malignancies혈액암이 있는 성인 환자의 SARS-CoV-2 백신 1차 및 2차 접종에 대한 면역 반응의 체계적인 검토 및 메타 분석Review Published on 2022-09-012022-09-11 Journal: International immunopharmacology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] 95% confidence interval 95%CI affected affecting anti-CD20 therapy antibody Antibody detection Antibody Response article booster dose booster doses calculated Cancer patients chronic lymphocytic leukemia CLL Complete conducted coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines develop Diagnosis disease doses evaluate first dose Google Google Scholar healthy subject healthy subjects Hematological malignancies Hematological malignancy higher risk highlight highlighting immune response Immunity immunization Immunocompromised immunogenicity immunosuppressive IMPROVE kinase inhibitors less leukemia lowest Lymphocytic leukemia lymphoma malignancy measure Meta-analysis mRNA mRNA-1273 Myeloma Patient Primary outcome response rate SARS-CoV-2 SARS-CoV-2 vaccine second dose secondary outcome Secondary outcomes seropositive Seropositivity severe coronavirus disease solid tumor solid tumors status subgroup subtype systematic review the disease the vaccine tumors tyrosine tyrosine kinase inhibitor tyrosine kinase inhibitors Vaccine vaccine dose vaccine's immunogenicity Web of Science [DOI] 10.1016/j.intimp.2022.109046 PMC 바로가기 [Article Type] Review
Is Mexico’s population hesitant towards COVID-19 vaccines? A 2021 survey on different levels of hesitancy and its determinantsResearch article Published on 2022-09-012022-10-05 Journal: SSM - Population Health [Category] 유전자 메커니즘, [키워드] acute respiratory syndrome Analysis association Characteristics complex conducted coronavirus country COVID-19 COVID-19 vaccine decrease determinant form Google Government Hesitancy in-depth analysis individual Latin America less matrix Mexico moderate pandemic performed physician SARS-CoV2 Side effect suffered Test the United State the vaccine understanding vaccination vaccination rates Vaccine Vaccine hesitancy Vaccine hesitancy determinants WHO World Health Organization’ [DOI] 10.1016/j.ssmph.2022.101207 [Article Type] Research article
Longitudinal dynamics of SARS-CoV-2 anti-receptor binding domain IgG antibodies in a wide population of health care workers after BNT162b2 vaccinationArticle Published on 2022-09-012022-11-15 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome Analysis analyzed Anti-RBD antibody Anti-RBD IgG antibody binding antibody binding domain BNT162b2 BNT162b2 vaccine coronavirus decrease domain doses female female participant HCWs Health care Health care worker health care workers highest highlight Humoral response IgG antibody IgG level immune response Immunoglobulin longitudinal male quantitative assay RBD SARS-CoV-2 second dose Sex significant difference spike glycoprotein Support the RBD the S1 subunit the spike protein the vaccine These data vaccination Vaccines were measured [DOI] 10.1016/j.ijid.2022.05.061 PMC 바로가기